Skip to content
Search

Latest Stories

EMIS Group acquires PharmOutcomes operators

EMIS Group has acquired Pinnacle Health Partnership and Pinnacle Systems Management– owners and operators of the PharmOutcomes platform.

The acquisition aims to drive widespread improvements in medicines management and to support pharmacy in providing more clinical services.


Shanel Raichura, clinical director at EMIS Health, said: “This is an exciting acquisition for EMIS Group. It will enable us to provide new services more quickly to our pharmacy customers – supporting them in their changing role.

“By joining up the technology, we will make it easier for pharmacy to deliver a wider range of patient services – including referrals from NHS 111 and from GP practices – and to fulfill the requirements of the new contract.

“There will also be the opportunity to develop new services, for example in response to the Patient Group Directions initiative.”

The deal will see PharmOutcomes become seamlessly embedded in EMIS Group’s ProScript Connect software – a leading community pharmacy system.

System improvements will also be made available to the wider marketplace and to non-EMIS Health customers, in line with EMIS Health’s commitment to interoperability.

Gary Warner and Kevin Noble, managing partners at Pinnacle Health Partnership LLP, will remain in charge post acquisition – along with their management team.

Gary Warner, who is also a practicing pharmacist on the Isle of Wight, said: “We created PharmOutcomes to help commissioners to understand and better engage with pharmacy.  Becoming part of EMIS Group will open up a host of new opportunities for us to build on our success and to further support pharmacy in its future role. It’s an exciting time.”

“We are reassuring all PharmOutcomes customers that our services will continue unchanged and the future developments will benefit EMIS Health and non-EMIS Health customers alike.”

PharmOutcomes is a web-based service management solution used by over 11,000 community pharmacies to record and manage nationally and locally commissioned patient services such as: flu vaccinations, the community pharmacist consultation service, and hospital discharge referral management.

It allows local and national level analysis and reporting on the effectiveness of commissioned services, helping to improve the evidence base for community pharmacy services.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less